
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Duchenne muscular dystrophy medical therapy
Introduction
Overview
Overview
Pharmacologic medical therapies for Duchenne muscular dystrophy include glucocorticoids and disease-modifying treatment.
Medical Therapy
Medical Therapy
- Pharmacologic medical therapies for Duchenne muscular dystrophy include glucocorticoids and disease-modifying treatment.[1][2]
Duchenne muscular dystrophy
- 1 Glucocorticoids
- Preferred regimenΒ : Prednisone 0.75 mg/kg PO per day q24h
- 2 Disease-modifying treatment
- Preferred regimen (1): Eteplirsen 30 mg/kg IV per week (infusion over 35 to 60 minutes)
- Preferred regimen (2): Ataluren 40 mg/kg PO per day q8h (10 mg/kg in the morning, 10 mg/kg at midday, and 20 mg/kg in the evening)
References
References
- β Finkel RS (September 2010). “Read-through strategies for suppression of nonsense mutations in Duchenne/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124)”. J. Child Neurol. 25 (9): 1158β64. doi:10.1177/0883073810371129. PMCΒ 3674569. PMIDΒ 20519671.
- β Cirak S, Arechavala-Gomeza V, Guglieri M, Feng L, Torelli S, Anthony K, Abbs S, Garralda ME, Bourke J, Wells DJ, Dickson G, Wood MJ, Wilton SD, Straub V, Kole R, Shrewsbury SB, Sewry C, Morgan JE, Bushby K, Muntoni F (August 2011). “Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study”. Lancet. 378 (9791): 595β605. doi:10.1016/S0140-6736(11)60756-3. PMCΒ 3156980. PMIDΒ 21784508.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
